Neuralink's Next Leap: Automated Brain-Computer Interfaces by 2026

Neuralink plans to begin high-volume production and fully automate surgical procedures for its brain-computer interface devices by 2026. The company, which started human trials in 2024, aims to assist those with spinal cord injuries and severe paralysis. It recently secured $650 million in funding.

Elon Musk's ambitious venture, Neuralink, has announced plans to initiate high-volume production of its brain-computer interface devices, with a goal of moving to fully automated surgical procedures by 2026. Musk disclosed these advancements on social media, highlighting a significant step forward in neurotechnology.

Neuralink's device, designed to aid individuals with conditions like spinal cord injuries, allows users to perform tasks via thought, such as playing video games and navigating the internet. The company's ongoing human trials began in 2024 following the resolution of safety issues previously flagged by the U.S. Food and Drug Administration.

In recent developments, 12 individuals with severe paralysis worldwide have successfully utilized Neuralink's implants to interface with digital and physical tools. Additionally, the company bolstered its financial standing by securing $650 million in a funding round held in June.

(With inputs from agencies.)